Technical Data
B1075-04B
Benzodiazepine (BZO)
Description:
The term benzodiazepine refers to the portion of the structure composed of a benzene ring (A) fused to a seven membered diazepine ring (B). Benzodiazepine is a central nervous system depressants, a sedative hypnotic agent. Benzodiazepine receptors are located on the alpha subunit of the GABA receptor located almost exclusively on postsynaptic nerve endings in the CNS (especially cerebral cortex). Benzodiazepines enhance the GABA transmitter in the opening of postsynaptic chloride channels which leads to hyperpolarization of cell membranes.

Applications:
Suitable for use in ELISA. Other applications not tested

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG19L57Purified
SizeStorageShippingSourceHost
1mg-20CBlue IceMouse
Concentration:
As reported
Immunogen:
Benzodiazepine (BSA).
Purity:
~95% (SDS-PAGE)
Form
Supplied as a liquid in PBS, pH 7.0, 0.02% sodium azide.
Specificity:
Recognizes Benzodiazepine (BZO).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.